The role of stem cell transplantation in the management of relapsed follicular lymphoma in the era of targeted therapies

被引：11

作者：

Norman, Jane E. ^{[1
]}

Schouten, Harry C. ^{[2
]}

Dreger, Peter ^{[3
]}

Robinson, Stephen P. ^{[4
]}

机构：

[1] Manchester Royal Infirm, Dept Haematol, Manchester, Lancs, England

[2] Univ Hosp Maastricht, Dept Internal Med Hematol, Maastricht, Netherlands

[3] Heidelberg Univ, Dept Haematol & Oncol, Heidelberg, Germany

[4] Bristol Oncol & Haematol Ctr, Dept Haematol, Bristol, Avon, England

来源：

BONE MARROW TRANSPLANTATION | 2019年 / 54卷 / 06期

关键词：

NON-HODGKIN-LYMPHOMA; TERM-FOLLOW-UP; BONE-MARROW-TRANSPLANTATION; PROGRESSION-FREE SURVIVAL; HIGH-DOSE THERAPY; CHRONIC LYMPHOCYTIC-LEUKEMIA; CHIMERIC-ANTIGEN-RECEPTOR; LOW-GRADE; OPEN-LABEL; PHASE-II;

D O I：

10.1038/s41409-018-0372-5

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

Patients with relapsed follicular lymphoma (FL) following first-line therapy have an increasing number of management strategies ranging from observation through to stem cell transplantation. There has been an exciting expansion in novel agents to treat FL, but at present there is not a universally accepted standard of care in the relapse setting. Decision-making can be difficult for the clinician as there is a paucity of data to compare the various relapse therapies available. This review will discuss conventional therapy for relapsed FL, consider the use of novel agents and explore the role and timing of autologous and allogeneic stem cell transplantation.

引用

页码：787 / 797

页数：11

共 50 条

[41] The role of haematopoietic stem cell transplantation for sickle cell disease in the era of targeted disease-modifying therapies and gene editing
de la Fuente, Josu
Gluckman, Eliane
Makani, Julie
Telfer, Paul
Faulkner, Lawrence
Corbacioglu, Selim
LANCET HAEMATOLOGY, 2020, 7 (12): : 902 - 911
[42] HIGH-DOSE THERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOR RELAPSED FOLLICULAR LYMPHOMA: THE ARGENTINEAN EXPERIENCE
Garcia, P.
De Goycoechea, D.
Berro, M.
Tabar, J.
Yantorno, S.
Nappal, J.
Rivas, M.
Prates, M.
Molnar, S.
Rizzi, M.
Basquiera, A.
Jarchum, G.
Milone, J.
Kusminsky, G.
Garcia, J.
HAEMATOLOGICA, 2012, 97 : 660 - 660
[43] PET/CT before autologous stem cell transplantation predicts outcome in refractory/relapsed follicular lymphoma
Marion Alcantara
Jehan Dupuis
Sylvain Mareschal
Anne Julian
Anne Ségolène Cottereau
Stéphanie Becker
Sydney Dubois
Lucie Oberic
Anne Huynh
Michel Meignan
Guy Laurent
Hervé Tilly
Corinne Haioun
Loïc Ysebaert
European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 215 - 221
[44] ALLOGENEIC REDUCED-INTENSITY STEM CELL TRANSPLANTATION WITH FLUDARABINE AND MELPHALAN FOR REFRACTORY OR RELAPSED FOLLICULAR LYMPHOMA
Ono, Y.
Mori, T.
Kato, J.
Aisa, Y.
Okamoto, S.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S236 - S236
[45] Reduced-intensity conditioning allogeneic stem cell transplantation for patients with chemoresistant or relapsed follicular lymphoma
de Lavallade, Hugues
Mohty, Mohamad
El-Cheikh, Jean
Cassier, Philippe A.
Faucher, Catherine
Furst, Sabine
Vey, Norbert
Stoppa, Anne-Marie
Sainty, Daniele
Arnoulet, Christine
Xerri, Luc
Gastaut, Jean-Albert
Blaise, Didier
Bouabdallah, Reda
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (03) : 408 - 410
[46] Autologous and allogeneic stem cell transplantation in follicular lymphoma
Van Besien, K
TRANSFUSION AND APHERESIS SCIENCE, 2005, 32 (01) : 45 - 53
[47] Stem cell transplantation in follicular lymphoma: progress at last?
W W Tse
H M Lazarus
K Van Besien
Bone Marrow Transplantation, 2004, 34 : 929 - 938
[48] Rituximab in autologous stem cell transplantation for follicular lymphoma
Schmitz, N
ANTI-CANCER DRUGS, 2001, 12 : S21 - S24
[49] Stem cell transplantation in follicular lymphoma: progress at last?
Tse, WW
Lazarus, HM
Van Besien, K
BONE MARROW TRANSPLANTATION, 2004, 34 (11) : 929 - 938
[50] Autologous Stem Cell Transplantation in Hodgkin Lymphoma-Latest Advances in the Era of Novel Therapies
Samara, Yazeed
Mei, Matthew
CANCERS, 2022, 14 (07)

← 1 2 3 4 5 →